Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James B. Frakes
James B. Frakes is recorded as CEO, Board Member and CFO at Aethlon Medical Inc (AEMD). Aethlon Medical Inc reported in an 8-K filed October 1, 2026 that James B. Frakes was appointed director, effective October 1, 2026. Aethlon Medical Inc reported in an 8-K filed February 23, 2026 that James B. Frakes was appointed director, effective February 19, 2026. Aethlon Medical Inc reported in an 8-K filed October 3, 2024 that James B. Frakes was appointed permanent Chief Executive Officer, effective October 3, 2024. Equibles holds 6 filed executive changes naming James B. Frakes; each is listed under recent activity with its source filing. The proxy statement of Aethlon Medical Inc reports total compensation of $826,922 for James B. Frakes in fiscal 2026, including a base salary of $500,000. Disclosed compensation is on record for 6 fiscal years. James B. Frakes has spoken on 15 earnings calls across 1 company, most recently for Aethlon Medical Inc on November 12, 2025.
“The Company’s stockholders elected five directors, each to hold office until the Company’s next annual meeting of stockholders, or until their successors are duly elected and qualified, subject to prior death, resignation, or removal, as follows:”
Aethlon Medical Inc Form 8-K, filed October 1, 2026
· Read the filing
“The Company's stockholders elected five directors, each to hold office until the Company's next annual meeting of stockholders, or until their successors are duly elected and qualified, subject to prior death, resignation, or removal, as follows:”
Aethlon Medical Inc Form 8-K, filed February 23, 2026
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
